Rhenman & Partners Asset Management AB - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 159 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$3,007,000
+44.9%
39,0000.0%0.51%
-15.6%
Q4 2014$2,075,000
+13.2%
39,0000.0%0.60%
+11.9%
Q3 2014$1,833,000
-29.9%
39,000
-7.1%
0.54%
-30.8%
Q2 2014$2,616,000
-1.7%
42,000
+6.1%
0.78%
-2.9%
Q1 2014$2,661,000
+33.1%
39,567
+4.1%
0.80%
+2.2%
Q4 2013$1,999,00038,0000.78%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders